Parabilis Medicines, Inc. (PBLS)
Financing Cash Flow
$1.14B
TTM · Period ending: · USD

PBLS Financing Cash Flow
What is financing cash flow?
Cash from issuing/repaying debt and equity.
PBLS financing cash flow history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.
| Period ending | Financing Cash Flow (USD) | Change |
|---|---|---|
| 64,382,000 | −17.55% | |
| 78,085,000 | — |
Frequently asked questions: PBLS financing cash flow
What is Parabilis Medicines, Inc. (PBLS)'s current financing cash flow?
Parabilis Medicines, Inc. (PBLS)'s latest reported financing cash flow (TTM) is $1.14B as of Sep 30, 2026. Cash from issuing/repaying debt and equity.
How much historical financing cash flow data is available for PBLS?
Stock Alarm Pro provides 2 dated annual fiscal periods observations for Parabilis Medicines, Inc. (PBLS)'s financing cash flow, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.
How can I compare PBLS's financing cash flow to peers or set an alert?
You can open PBLS's financing cash flow in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on PBLS delivered by push, email, or phone call.
Explore More
Explore 130+ historical metrics & ratios
Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance